Lingua

Stivarga approved for Metastatic Colorectal Cancer

24/09/2013

The U.S. Food and Drug Administration (FDA) has approved Stivarga® (regorafenib) for the treatment of patients with metastatic colorectal cancer that has progressed following previous treatment.

Novartis drug Ilaris® approved by FDA

19/07/2013
Novartis drug Ilaris® approved by FDA to treat active systemic juvenile idiopathic arthritis, a serious form of childhood arthritis

Stelara (ustekinumab)

19/07/2013

Stelara is a solution for injection that contains the active substance ustekinumab. It is available in a vial or in a prefilled syringe. Each vial or syringe contains either 45 or 90 mg ustekinumab.

Iluvien (sustained release fluocinolone acetonide)

19/07/2013
Diabetic Macular Edema

Kadcyla (trastuzumab emtansine)

18/07/2013

FDA approves Roche's Kadcyla (trastuzumab emtansine), the first antibody-drug conjugate for treating HER2-positive metastatic breast cancer

Jakavi

18/07/2013

Novartis drug Jakavi® improved overall survival of myelofibrosis patients and impacted an underlying mechanism of disease

Bayer’s Novel Anticoagulant Xarelto® now also Approved in the EU

02/11/2008
Bayer will start marketing the new oral, once-daily anticoagulant very soon / First-in-class product to demonstrate superior efficacy to current standard of care

PRILOCAINE HYPERBAR SINTETICA in esclusiva per l'Italia

28/10/2008

A partire dal 01 novembre 2008 Unipharma SA distribuirà in esclusiva in Italia il prodotto:

PRILOCAINE HYPERBAR SINTETICA  2%  10 fiale  5 ml

Jerini Receives European Commission Approval for Firazyr (Icatibant) in the Treatment...

Jerini Receives European Commission Approval for Firazyr (Icatibant) in the Treatment of HAE

Diventa fornitore unipharma

Diventa cliente unipharma

FDA Approves Kinrix - New Combination Vaccine for Children

07/07/2008
GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine], the first combination vaccine to offer protection against diphtheria, tetanus, pertussis and polio diseases in one shot.

Acquisizione di Pharmion da parte di Celgene

07/07/2008
Celgene Corporation ha comunicato in data 11 marzo 2008 il completamento dell'acquisizione, del valore di 2.9 miliardi di dollari, di Pharmion Corporation.

Recapiti

DIVISIONE IMPORT EXPORT

Tel. +41 (0)91 985 62 11
Fax. +41 (0)91 985 62 22
Clienti: sales@unipharma.ch
Fornitori: purchase@unipharma.ch

SEDE

Unipharma SA Via Pian Scairolo
CH - 6917 Barbengo, Lugano
Tel. +41 (0)91 985 62 11
Fax. +41 (0)91 985 62 22
Generale: unipharma@unipharma.ch